DABUR RESEARCH

Dabur Group is among the largest healthcare companies in India with a market capitalization of $12 billion USD... Our services encompass In Vitro, Ex-Vivo, and In Vivo Pharmacology, as well as Exploratory and GLP Toxicology and DMPK studies. Originating from the Dabur group of companies, we began operating independently as a preclinical service provider in 2008 following a strategic spin-off. We serve the global biotech, pharma, phytopharmaceuticals, cosmeceuticals, and academic sectors... At DRF, we remain focused on excellence, innovation, and impact, enabling us to drive scientific progress while delivering meaningful contributions to society and the pharmaceutical industry.

Also known as: Dabur Group, Dabur Research Foundation, DRF